Synergistic Induction of Cyclooxygenase-2 by Transforming Growth Factor-β1 and Epidermal Growth Factor Inhibits Apoptosis in Epithelial Cells

Neoplasia

Volumn 1, Issue 6, 1999, Pages 508-517

  Saha, Debabrata ^a   Datta, Pran K ^a   Sheng, Hongmiao ^a   Morrow, Jason D ^b   Wada, Michihiko ^a   Moses, Harold L ^a   Beauchamp, R Daniel ^a,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; COX 2; EGF; TGF

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; ISOENZYME; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYME INDUCTION; EPITHELIUM CELL; HUMAN; MINK; PHYSIOLOGY; RAT; TIME;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MINK; MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033290356     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900051     Document Type: Article

References (65)

1. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jannet JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, and Smithies O (1995). Prostaglandin synthase 2 gene disruption cause severe renal pathology in the mouse. Cell 83, 473-482.
2. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, and Smithies O (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethocin-induced gastric ulceration. Cell 83, 483-492.
3. Tsujii M, and DuBois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
4. Smith WL, and Dewitt DL (1996). Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62, 167-215.
5. Marnett LJ (1992). Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52, 5575-5589.
6. Yokoyama C, and Tanabe T (1989). Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophysics Res Commun 165, 888-894.
7. Fletcher BS, Kujubu DA, Perrin DM, and Hershman HR (1992). Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 267, 4338-4344.
8. Jones DA, Carlton D, McIntyre MT, Zimmerman GA, and Prescott SM (1993). Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268, 9049-9054.
9. Williams CS, and DuBois RN (1996). Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270, G393-G400.
10. O'Neill GP, and Ford-Hutchinson AW (1993). Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330, 379-384.
11. Min mouse model. Cancer Res 56, 710-714.
12. Kawamori T, Rao CV, Seibert K, and Reddy BS (1998). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58, 409-412.
13. Reddy BS, Rao CV, and Seibert K (1996). Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56, 4566-4569.
14. Williams CW, Luongo C, Radhika A, Zhang T, Lamps L, Nanney LB, Beauchamp RD, and DuBois RN (1996). Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111, 1134-1140.
15. Ebehart CW, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, and DuBois RN (1994). Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188.
16. Kargman S, O'Neill G, Vickers P, Evans J, Mancini J, and Jothy S (1995). Expression of prostaglandin G/H synthase-1 and-2 in human colorectal cancer. Cancer Res 55, 2556-2559.
17. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, and Hla T (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55, 3785-3789.
18. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, and Prescott SM (1996). Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 93, 4816-4820.
19. Singh J, Hamid R, and Reddy BS (1997). Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post-initiation stage of colon carcinogenesis. Cancer Res 57, 3465-70.
20. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomo T, Sugiura T, and Takahashi T (1998). Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specially in adenocarcinomas. Cancer Res 58, 3761-3764.
21. Tsujii M, Kawano S, and DuBois RN (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94, 3336-3340.
22. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, and DuBois RN (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716.
23. 2 synthase. J Biol Chem 263, 7846-7854.
24. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsy PJ, Chinnery R, Kirkland SC, DuBois RN, Jetton TL, and Morrow JD (1997). Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 94, 657-662.
25. DuBois RN, Awad J, Morrow J, Roberts LJ, and Bishop PR (1994). Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 93, 493-498.
26. 2 production in human gingival fibroblasts stimulated with interleukin-1 beta and epidermal growth factor. Biochem Biophys Res Commun 257, 528-532.
27. Diaz A, Chepenik KP, Korn JH, Reginato AM, and Jimenez SA (1998). Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res 241, 222-229.
28. Hida T, Leyton J, Makheja AN, Ben-Av P, and Hla T (1998). Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res 18, 775-782.
29. 2 and cyclooxygenase 2 in human squamous carcinoma A431 cells. Prostaglandins 53, 355-369.
30. Sheng H, Shao J, Hooton EB, Tsujii M, DuBois RN, and Beauchamp RD (1997). Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ 8, 463-470.
31. Gilbert RS, Reddy ST, Targan S, and Harschman HR (1994). TGF-β1 augments expression of the TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells. Cell Mol Biol Res 40, 653-660.
32. Gilbert RS, Reddy ST, Kujubu DA, Xie W, Luner S, and Herschman HR (1994). Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J Cell Physiol 159, 67-75.
33. Berchuck A, MacDonald PC, Milewich L, and Casey ML (1989). Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells. Prostaglandins 38, 453-464.
34. Reddy ST, Gilbert RS, Xie W, Luner S, and Herschman HR (1994). TGF-beta 1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages. J Leukocyte Biol 55, 192-200.
35. Xie W, and Herschman HR (1995). v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcriptional factor. J Biol Chem 270, 27622-27628.
36. Xie W, and Herschman HR (1996). Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271, 31742-31748.
37. Guan Z, Buckman SY, Pentland AP, Templeton DJ, and Morrison AR (1998). Induction of cyclooxygenase-2 by the activated MEKK1/SEK1/ MKK4 p38 mitogen-activated protein kinase pathway. J Biol Chem 273, 12901-12908.
38. Subbaramaiah K, Chung WJ, and Danenberg AL (1998). Ceramide regulates the transcription of cyclooxygenase-2. J Biol Chem 273, 32943-32949.
39. Sheng HM, Williums CS, Shao J, Peng L, DuBois RN, and Beauchamp RD (1998). Induction of cyclooxygenase-2 by activated Ha-Ras oncogene in rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 273, 22120-22127.
40. Kretzschmar M, Doody J, Timokhina I, and Massague J (1999). A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13, 804-816.
41. Oberhammer F, Wilson LW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, and Sikorska M (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intemucleosomal fragmentation. EMBO J 12 (9), 3679-84.
42. Warna JL, Attisano L, Wieser R, Ventura F, and Massague J (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347.
43. Dudley DT, Pang L, Decker ST, Bridges AJ, and Saltiel AR (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92, 7686-7689.
44. 2. J Biol Chem 271, 27723-27729.
45. Levitzki A, and Gazit A (1995). Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788.
46. Herrmann M, Lorenz H-M, Voll R, Grunke M, Woith W, and Kalden JR (1994). A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22, 5506-5507.
47. Elias JA, Gustilo K, Baeder W, and Freundlich B (1987). Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol 135, 3812-3816.
48. 2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha-1. J Immunol 143, 1989-1995.
49. 2 stimulation. J Exp Cell Res 222, 379-384.
50. Modeer T, Yucel-Lindberg T, Lerner UH, and Andersen G (1993). Epidermal growth factor potentiates interleukin 1 and tumor necrosis factor-induced prostaglandin biosynthesis in human gingival fibroblasts. Cytokine 5, 198-204.
51. Song JH, Sirois J, Houde A, and Murphy BD (1998). Cloning and developmental expression, and immunohistochemistry of cyclooxygenase 2 in the endometrium during embryo implantation and gestation in the mink (mustela vision). Endocrinology 139, 3629-3636.
52. Duffy DC, Calcaterra TC, and Lichtenstein AK (1996). Regulation of transforming growth factor-beta 1-mediated apoptosis in head and neck squamous cell carcinoma. Laryngoscope 106, 889-894.
53. Oberhammer F, Fritish G, Pavelka M, Froschel G, Tiefenbacher R, Puricho T, and Schulte-Hermann R (1992). Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease. Toxicol Lett 64-65, 701-70.
54. Zushi S, Shinomura Y, Kiyohara T, Miyazaki Y, Kondo S, Sugimachi M, Higashimoto T, Kanayama S, and Matsuzawa Y (1998). STAT3 mediates the survival signal in oncogenic ras transfected intestinal epithelial cells. Int J Cancer 78, 326-330.
55. McClellan M, Keivit P, Auersperg N, and Rodland K (1999). Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells. Exp Cell Res 246, 471-479.
56. Fabregat I, Sanchez A, Alverez AM, Nakamura T, and Benito M (1996). Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-beta in fetal hepatocytes in primary culture. FEBS Lett 384, 14-18.
57. Fox JC, and Shanley JR (1996). Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 271, 12578-12584.
58. Gardner AM, and Johnson GL (1996). Fibroblast growth factor-2 suppress of tumor necrosis factor α-mediated apoptosis requires ras and the activation of mitogen-activated protein kinase. J Biol Chem 271, 14560-14566.
59. 2 inhibits apoptosis in human neutrophilic polymorpho-nuclear leukocytes: role of intracellular cyclic AMP levels. Exp Hematol 26, 895-902.
60. 2 in human colon cancer cells. Cancer Res 58, 362-366.
61. Liu X-H, Yao S, Krischenbaum A, and Levine AC (1998). NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58, 4245-4249.
62. Ballif B, Mincek N, Barret J, Wilson M, and Simmons D (1996). Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein. Proc Natl Acad Sci USA 93, 5544-5549.
63. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR (1995). PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494.
64. Terada Y, Nakashima O, Inoshita S, Kuwahara M, Sasaki S, and Marumo F (1999). Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3/6-p38K and MKK1-MAPK. Nephrol Dial Transplant 14, 45-47.
65. Wang W, Zhou G, Hu MCT, Yao Z, and Tan TH (1997). Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem 272, 22771-22775.